fda

Mindstate Uses AI to Design “Next-Gen” Psychedelics Combined With 5-MeO-MiPT 
Lykos, MAPS Cut Staff As New Leadership Takes Charge of MDMA-AT Research
Republican Congressman Jack Bergman Rallies Support For Psychedelic-Assisted Therapies
FDA Denies the Lykos Therapeutics Application for MDMA-Assisted Therapy
Lawmakers Express Bipartisan Support for MDMA-Assisted Therapy to Treat PTSD
Addiction Doctor Endorses MDMA-AT for Treatment of PTSD 
How the FDA MDMA Decision Affects Therapists and Trainers
Stakeholders Address Alleged Research Bias As Veterans Endorse MDMA-AT
Can Lykos Therapeutics Address MDMA-AT Safety Concerns Ahead of FDA Decision?
Lykos Responds to Opposition by FDA Advisors to MDMA-Assisted Therapy